Destiny Pharma PLC
LSE:DEST
Destiny Pharma PLC
LSE:DEST
Price:
18.25 GBX
2.82%
Market Closed
Updated:
May 2, 2024
Destiny Pharma PLC
Cash from Financing Activities
|
Destiny Pharma PLC
Cash from Financing Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Destiny Pharma PLC
LSE:DEST
|
Cash from Financing Activities
£6.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Financing Activities
$21.1m
|
CAGR 3-Years
149%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Financing Activities
-$883k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Financing Activities
$250m
|
CAGR 3-Years
58%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Financing Activities
£34.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
221%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Financing Activities
-£20.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Destiny Pharma PLC's Cash from Financing Activities?
Cash from Financing Activities
6.7m
GBP
6.7m
GBP
Based on the financial report for Jun 30, 2023, Destiny Pharma PLC's Cash from Financing Activities amounts to 6.7m GBP.
What is Destiny Pharma PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-17%
-17%
Over the last year, the Cash from Financing Activities growth was 11%.
You don't have any saved screeners yet
